Join Dr. Jeffrey Infante as he discusses the advances in combination therapies for melanoma, as well as the future of these treatments. Topics include:
- B-Raf
- Vemurafenib
- Trametinib
- Combination B-Raf/MEK
- Other Targeted Combination Strategies
- RAF & Immunotherapy Combinations
- Sequencing Strategies
Facilitators:
Jeffrey Infante, MD
Director of Drug Development, Sarah Cannon Research Institute
Hematologist/Oncologist, Tennessee Oncology PLLC
Catherine Poole, Melanoma International Foundation
